Global Total Artificial Heart Market Growth 2025-2031

Publication ID:

LPI07252188

Publication Date:

July 2, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Total Artificial Heart market size is predicted to grow from US$ 67.3 million in 2025 to US$ 228 million in 2031; it is expected to grow at a CAGR of 22.5% from 2025 to 2031.
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
The 鈥淭otal Artificial Heart Industry Forecast鈥� looks at past sales and reviews total world Total Artificial Heart sales in 2024, providing a comprehensive analysis by region and market sector of projected Total Artificial Heart sales for 2025 through 2031. With Total Artificial Heart sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Total Artificial Heart industry.
This Insight Report provides a comprehensive analysis of the global Total Artificial Heart landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Total Artificial Heart portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Total Artificial Heart market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Total Artificial Heart and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Total Artificial Heart.
This report presents a comprehensive overview, market shares, and growth opportunities of Total Artificial Heart market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
SynCardia
Others
Segmentation by Application:
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Total Artificial Heart market?
What factors are driving Total Artificial Heart market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Total Artificial Heart market opportunities vary by end market size?
How does Total Artificial Heart break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Total Artificial Heart Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Total Artificial Heart by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Total Artificial Heart by Country/Region, 2020, 2024 & 2031
2.2 Total Artificial Heart Segment by Type
2.2.1 SynCardia
2.2.2 Others
2.3 Total Artificial Heart Sales by Type
2.3.1 Global Total Artificial Heart Sales Market Share by Type (2020-2025)
2.3.2 Global Total Artificial Heart Revenue and Market Share by Type (2020-2025)
2.3.3 Global Total Artificial Heart Sale Price by Type (2020-2025)
2.4 Total Artificial Heart Segment by Application
2.4.1 Dilated Cardiomyopathy
2.4.2 Ischemic Cardiomyopathy
2.4.3 Others
2.5 Total Artificial Heart Sales by Application
2.5.1 Global Total Artificial Heart Sale Market Share by Application (2020-2025)
2.5.2 Global Total Artificial Heart Revenue and Market Share by Application (2020-2025)
2.5.3 Global Total Artificial Heart Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Total Artificial Heart Breakdown Data by Company
3.1.1 Global Total Artificial Heart Annual Sales by Company (2020-2025)
3.1.2 Global Total Artificial Heart Sales Market Share by Company (2020-2025)
3.2 Global Total Artificial Heart Annual Revenue by Company (2020-2025)
3.2.1 Global Total Artificial Heart Revenue by Company (2020-2025)
3.2.2 Global Total Artificial Heart Revenue Market Share by Company (2020-2025)
3.3 Global Total Artificial Heart Sale Price by Company
3.4 Key Manufacturers Total Artificial Heart Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Total Artificial Heart Product Location Distribution
3.4.2 Players Total Artificial Heart Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Total Artificial Heart by Geographic Region
4.1 World Historic Total Artificial Heart Market Size by Geographic Region (2020-2025)
4.1.1 Global Total Artificial Heart Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Total Artificial Heart Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Total Artificial Heart Market Size by Country/Region (2020-2025)
4.2.1 Global Total Artificial Heart Annual Sales by Country/Region (2020-2025)
4.2.2 Global Total Artificial Heart Annual Revenue by Country/Region (2020-2025)
4.3 Americas Total Artificial Heart Sales Growth
4.4 APAC Total Artificial Heart Sales Growth
4.5 Europe Total Artificial Heart Sales Growth
4.6 Middle East & Africa Total Artificial Heart Sales Growth
5 Americas
5.1 Americas Total Artificial Heart Sales by Country
5.1.1 Americas Total Artificial Heart Sales by Country (2020-2025)
5.1.2 Americas Total Artificial Heart Revenue by Country (2020-2025)
5.2 Americas Total Artificial Heart Sales by Type (2020-2025)
5.3 Americas Total Artificial Heart Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Total Artificial Heart Sales by Region
6.1.1 APAC Total Artificial Heart Sales by Region (2020-2025)
6.1.2 APAC Total Artificial Heart Revenue by Region (2020-2025)
6.2 APAC Total Artificial Heart Sales by Type (2020-2025)
6.3 APAC Total Artificial Heart Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Total Artificial Heart by Country
7.1.1 Europe Total Artificial Heart Sales by Country (2020-2025)
7.1.2 Europe Total Artificial Heart Revenue by Country (2020-2025)
7.2 Europe Total Artificial Heart Sales by Type (2020-2025)
7.3 Europe Total Artificial Heart Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Total Artificial Heart by Country
8.1.1 Middle East & Africa Total Artificial Heart Sales by Country (2020-2025)
8.1.2 Middle East & Africa Total Artificial Heart Revenue by Country (2020-2025)
8.2 Middle East & Africa Total Artificial Heart Sales by Type (2020-2025)
8.3 Middle East & Africa Total Artificial Heart Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Total Artificial Heart
10.3 Manufacturing Process Analysis of Total Artificial Heart
10.4 Industry Chain Structure of Total Artificial Heart
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Total Artificial Heart Distributors
11.3 Total Artificial Heart Customer
12 World Forecast Review for Total Artificial Heart by Geographic Region
12.1 Global Total Artificial Heart Market Size Forecast by Region
12.1.1 Global Total Artificial Heart Forecast by Region (2026-2031)
12.1.2 Global Total Artificial Heart Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Total Artificial Heart Forecast by Type (2026-2031)
12.7 Global Total Artificial Heart Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 BiVACOR
13.1.1 BiVACOR Company Information
13.1.2 BiVACOR Total Artificial Heart Product Portfolios and Specifications
13.1.3 BiVACOR Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BiVACOR Main Business Overview
13.1.5 BiVACOR Latest Developments
13.2 SynCardia
13.2.1 SynCardia Company Information
13.2.2 SynCardia Total Artificial Heart Product Portfolios and Specifications
13.2.3 SynCardia Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 SynCardia Main Business Overview
13.2.5 SynCardia Latest Developments
13.3 Jarvik Heart
13.3.1 Jarvik Heart Company Information
13.3.2 Jarvik Heart Total Artificial Heart Product Portfolios and Specifications
13.3.3 Jarvik Heart Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jarvik Heart Main Business Overview
13.3.5 Jarvik Heart Latest Developments
13.4 CARMAT
13.4.1 CARMAT Company Information
13.4.2 CARMAT Total Artificial Heart Product Portfolios and Specifications
13.4.3 CARMAT Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 CARMAT Main Business Overview
13.4.5 CARMAT Latest Developments
13.5 AbioMed
13.5.1 AbioMed Company Information
13.5.2 AbioMed Total Artificial Heart Product Portfolios and Specifications
13.5.3 AbioMed Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AbioMed Main Business Overview
13.5.5 AbioMed Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂